Finally, our results suggest that IGF-1-upregulated miR-513a-5p signaling attenuated glioma cell sensitivity to TMZ via inhibiting NEDD4L-inactivated WNT/β-catenin pathways. The gene discussed is NEDD4L; the disease is glioma.